scorecardresearch
Add as a preferred source on Google
Sunday, September 28, 2025
TopicBiocon

Topic: Biocon

India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba

The drug will go under trial in six hospitals in India, including AIIMS-Delhi, KEM Hospital in Mumbai and Narayana Health in Bengaluru. 

Biocon’s blood purification device gets regulator nod for treating critical Covid patients

CytoSorb was introduced in 2013 for Sepsis patients. It has now been allowed to treat critical Covid patients to help reduce their cytokines levels.

Made-in-India Covid-19 vaccine could be ready in a year, says Biocon’s Kiran Mazumdar-Shaw

In an interview to ThePrint, Biocon co-founder Kiran Mazumdar-Shaw says India is ahead of other countries in flattening the Covid-19 curve.

On Camera

Aamir Khan and Salman Khan are still dodging and deflecting the age question, 20 yrs later

On the first episode of Two Much With Kajol and Twinkle, Aamir Khan and Salman Khan were confronted with another hypocrisy: age gaps. And they didn't come out looking good.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.